查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702038

2025 年至 2033 年抗感染藥物市場報告（按類型、給藥途徑（局部、口服、靜脈注射等）、配銷通路和地區分類）

Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球抗感染藥物市場規模達 1,388 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 1,800 億美元，2025-2033 年期間的成長率 (CAGR) 為 2.93%。

抗感染藥物是透過抑制傳播或直接殺死傳染源來對抗感染的藥物。這些藥物包括抗生素、抗病毒藥、抗黴菌藥、抗瘧藥、驅蟲藥和抗原蟲藥。它們通常透過口服、腸胃外和局部途徑給藥。它們被廣泛用於治療輕微傳染病，包括肺炎和結核病。除此之外，在剖腹產和關節置換等常規手術中也會使用抗感染藥物，這些手術具有很高的嚴重感染風險。

抗感染藥物市場趨勢：

全球抗感染藥物市場主要受到全球傳染病發生率上升的推動。反不定式用於治療感染，包括病毒、細菌、寄生蟲和真菌。此外，採用不同策略配製的新型藥物（如天然產物、群體感應抑制劑、生物膜破壞劑、鎵基藥物、環糊精抑制劑和基於光的抗菌劑）的開發正在為市場成長提供動力。與此相符的是，藥物發現程序的最新創新，例如幹細胞和器官晶片（OOC）技術，旨在加強藥物試驗過程，為市場創造積極的前景。此外，由於 COVID-19 疾病的出現以及曲霉病、侵襲性念珠菌病和毛黴菌病等誘發感染，產品採用率不斷提高，這也增強了市場的成長。除此之外，監管機構批准的新型抗感染藥物數量不斷增加也是另一個促進成長的因素。此外，預計政府優惠政策的實施、對開發新型創新藥物的投資增加、個人對傳染病認知的提高以及醫療保健基礎設施的快速改善將在未來幾年推動市場的成長。

本報告回答的關鍵問題

  • 2024 年全球抗感染藥物市場規模？ 2025-2033年全球抗感染藥物市場的預期成長率是多少？
  • 推動全球抗感染藥物市場發展的關鍵因素有哪些？
  • COVID-19 對全球抗感染藥物市場有何影響？
  • 全球抗感染藥物市場按類型分類是怎樣的？
  • 根據給藥途徑，全球抗感染藥物市場如何分佈？
  • 根據配銷通路，全球抗感染藥物市場分佈如何？
  • 全球抗感染藥物市場的主要區域有哪些？
  • 全球抗感染藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球抗感染藥物市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 抗菌
  • 抗真菌
  • 抗病毒劑

第7章：市場區隔：依行政途徑

  • 外用
  • 口服
  • 靜脈注射（IV）
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 專業藥房
  • 網路商店
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Cipla Health Ltd. (Cipla Limited)
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson
    • Lupin Limited
    • Sandoz AG (Novartis AG)
    • Sun Pharmaceutical Industries Limited
Product Code: SR112025A6073

The global anti-infectives market size reached USD 138.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 180.0 Billion by 2033, exhibiting a growth rate (CAGR) of 2.93% during 2025-2033.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

Breakup by Type:

  • Antibacterial
  • Antifungal
  • Antiviral

Breakup by Route of Administration:

  • Topical
  • Oral
  • Intravenous (IV)
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Speciality Pharmacies
  • Online Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global anti-infectives market in 2024?
  • 2.What is the expected growth rate of the global anti-infectives market during 2025-2033?
  • 3.What are the key factors driving the global anti-infectives market?
  • 4.What has been the impact of COVID-19 on the global anti-infectives market?
  • 5.What is the breakup of the global anti-infectives market based on the type?
  • 6.What is the breakup of the global anti-infectives market based on the route of administration?
  • 7.What is the breakup of the global anti-infectives market based on distribution channel?
  • 8.What are the key regions in the global anti-infectives market?
  • 9.Who are the key players/companies in the global anti-infectives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-infectives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Antibacterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antifungal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antiviral
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intravenous (IV)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cipla Health Ltd. (Cipla Limited)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 GlaxoSmithKline plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Glenmark Pharmaceuticals Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Lupin Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sandoz AG (Novartis AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-infectives Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Anti-infectives Industry: SWOT Analysis
  • Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
  • Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Anti-infectives Market: Competitive Structure
  • Table 7: Global: Anti-infectives Market: Key Players